Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback
نویسندگان
چکیده
BACKGROUND Antibiotics and proton pump inhibitors (PPIs) are associated with Clostridium difficile infection (CDI). Both a computer order entry alert to highlight this association as well as antimicrobial stewardship directed prospective audit and feedback represent novel interventions to reduce the co-administration of antibiotics and PPIs among hospitalized patients. METHODS Consecutive patients admitted to two General Internal Medicine wards from October 1, 2010 until March 31, 2013 at a teaching hospital in Toronto, Ontario, Canada were evaluated. The baseline observation period was followed by the first phase, which involved the creation of a computerized order entry alert that was triggered when either a PPI or an antibiotic was ordered in the presence of the other. The second phase consisted of the introduction of an antibiotic stewardship-initiated prospective audit and feedback strategy. The primary outcome was the co-administration of antibiotics and PPIs during each phase. RESULTS This alert led to a significant reduction in the co-administration of antibiotics and PPIs adjusted for month and secular trends, expressed as days of therapy per 100 patient days (4.99 vs. 3.14, p < 0.001) The subsequent introduction of the antibiotic stewardship program further reduced the co-administration (3.14 vs. 1.80, p <0.001). No change was observed in adjusted monthly CDI rates per 100 patient care days between the baseline and alert cohorts (0.12 vs. 0.12, p = 0.99) or the baseline and antibiotic stewardship phases (0.12 vs. 0.13, p = 0.97). CONCLUSIONS Decreasing the co-administration of PPIs and antibiotics can be achieved using a simple automatic alert followed by prospective audit and feedback.
منابع مشابه
Reducing co-administration of clopidogrel and proton pump inhibitors in acute coronary syndromes.
BACKGROUND Recent concerns about clopidogrel and proton pump inhibitor (PPI) co-administration in patients following an acute coronary syndrome (ACS) led us to investigate our practice. Guidance recommends that omeprazole and esomeprazole should not be co-administered with clopidogrel as they can decrease its efficacy. Pantoprazole and lansoprazole are safer for use in these cases. METHODS Pa...
متن کاملAttitudes and Knowledge of Hormozgan University of Medical Sciences Nurses Regarding the Implementation of Computerized Physician Order Entry
Introduction: Despite potential benefits of CPOE (Computerized Physician Order Entry) systems, recent studies have cast some doubts on their role in reducing errors. CPOE systems with poorly designed interfaces have proven to cause dissatisfaction and introduce new kinds of errors in the ordering process. The main objective of this study is to identify problems related to a CPOE medication syst...
متن کاملنفریت بینابینی حاد ناشی از پنتوپرازول: گزارش موردی
Pantoprazole is a proton-pump inhibitor that is commonly prescribed for the treatment of gastroesophageal reflux-related disorders. Acute interstitial nephritis is an uncommon though important side-effect of these classes of drugs. We reported a case with acute interstitial nephritis due to pantoprazole. A 25-year-old woman from Ardabil was admitted to our hospital with the complaint of fever, ...
متن کاملSystematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.
AIM To perform a systematic review of the efficacy of rabeprazole-based therapies in Helicobacter pylori eradication, and to conduct a meta-analysis comparing the efficacy of rabeprazole and other proton pump inhibitors when co-prescribed with antibiotics. METHODS Studies evaluating rabeprazole plus antibiotics were considered. Only randomized trials comparing rabeprazole and other proton pum...
متن کاملDelayed elimination of methotrexate associated with co-administration of proton pump inhibitors.
AIM We conducted a retrospective non-interventional cohort study to analyze the impact of proton pump inhibitors co-administration on methotrexate elimination in cancer patients receiving treatment protocol with the antifolate at high dose (>1 g/m(2) intravenously). PATIENTS AND METHODS Between 2005 and 2008, 79 patients (mean age: 48.8 years; range: 16-76 years) were treated by high dose met...
متن کامل